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Abstract To explore the molecular nd cellular mechanisms associated with photoreceptor death in retinitis pigmentosa (RP), we have investigated 
altered transcriptional ctivity in RP retinas by a differential cDNA screening approach. We identified aclone (K222) showing over-expression in 
simplex RP retinas compared with controls. K222 encodes a partial cDNA of the human tissue inhibitor f metalloproteinases-3 (TIMP3) gene, a 
member of a family of genes implicated in extracellular matrix (ECM) remodelling. Increased expression of TIMP3 in degenerating RP retinas may 
reflect restructuring of the ECM architecture, and disruption of photoreceptor-matrix interactions could contribute to activation of apoptotic cell 
death processes. 
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1. Introduction 
Retinitis pigmentosa (RP) is the term given to a heterogene- 
ous group of retinal diseases, affecting approximately 1 in 4000 
people, in which progressive degeneration of the photorecep- 
tors occurs, resulting in night blindness and contraction of the 
visual fields (reviewed in [ 11). The genetic basis for a substantial 
proportion of cases is clear: transmission may be via autosomal 
dominant, autosomal recessive, or X-linked modes, and in an 
increasing number of dominant and certain recessive forms the 
causal genetic defects have been identified, occurring in genes 
expressed primarily in the photoreceptors. However, simplex 
or isolated cases also frequently occur, and can account for up 
to 58% of all RP types according to some studies [2]. 
The cellular mechanisms leading from the gene defects to 
photoreceptor cell death in RP are poorly understood. Recent 
investigations of mouse models of RP have indicated that the 
final stages of photoreceptor demise occur via apoptosis [3-S], 
but the earlier triggers of this process are unknown. In seeking 
to gain insight into these mechanisms, we have analysed gene 
expression in retinas affected by RP using the technique of 
differential screening of cDNA libraries. We previously de- 
tected increased expression in RP retinas of the mRNA for the 
multifunctional glycoprotein clusterin [6], the gene for which is 
widely over-expressed in apoptotic and neurodegenerative tis- 
sues. Here we report identification of a second differentially 
expressed gene, tissue inhibitor of metalloproteinases-3 
(TIMP3), which shows increased mRNA expression in retinas 
affected by simplex RP, and discuss the possible significance of 
this finding in relation to the mechanisms of photoreceptor 
degeneration. 
2. Experimental 
2.1. Tissues 
Control human eyes from adult donors with no history of ocular 
disease were obtained from the UK Transplant Support Service 
(Bristol); control brain was from the MRC Brain Bank Laboratory, 
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Cambridge; and other control tissues were from St. Thomas’ Hospital. 
Eyes from patients (or their relatives) affected by RP were obtained 
through the British Retinitis Pigmentosa Society (BRPS) Eye Donor 
Scheme. Enucleated eyes or other tissues were dissected and stored 
frozen in liquid nitrogen or at -70°C until used for total RNA extrac- 
tion. The postmortem interval (pmi) between death and freezing was 
recorded where possible. For donors of control tissues, the details were 
as follows: Donor NRl (normal retina), female, age 77 years, pmi less 
than 8 h; Donor NR2 (normal retina), female, age 89 years, pmi = 11.5 
h; Donor NR3 (normal retina), male, age 67 years, pmi = 7 h; Donor 
NBr (normal brain), male, age 34 years, pmi = 6 h; Donor NLv (normal 
liver), male, age 58 years, pmi = 36 h. 
For the donors of retinal tissues obtained through the BRPS Donor 
Scheme, the details were as follows: Donor RPI, male, age 79 years, 
pmi not greater than 24 h, simplex RP; Donor RP2, male, age 81 years, 
pmi = 32 h, simplex RP; Don& RP3, female, age 85 years,pmi = 11.5 
h, carrier of X-linked RP with pigmentary deposits in retina and histo- 
logical evidence of some photoreceptor loss; Donor RP4, female, age 
92 years, pmi = 26 h, unaffected (latent) carrier of RP. 
2.2. RNA extraction, Northern and RNA dot blot analysis, and reverse 
transcription PCR 
RNA extraction and Northern blotting were as previously described 
[6]. For dot blots, 1 pg samples were denatured in formamide/formalde- 
hyde solution and spotted onto nylon membrane (Amersham Int., UK) 
according to the manufacturer’s instructions. Isolated cDNA inserts or 
control /?-actin cDNA were labelled with c@P]dCTP using the Meg- 
aprime kit (Amersham Int., UK) and hybridized to the blots in the 
presence of 50% formamide at 42°C overnight, followed by stringent 
washing and autoradiography. The probes were stripped off between 
separate hybridizations. Quantification of autoradiographic signals 
(maximum peak values) was performed using a laser densitometer 
(LKB, Sweden). Analysis of expression by reverse transcription PCR 
was performed on 1 /g samples of control retinal RNA, using random 
hexamers to prime cDNA synthesis [I. Oligonucleotide primers for 
PCR were obtained through the Human Genome Mapping Project 
Resource Centre, Harrow, UK, and from Pharmacia Biotech, Sweden. 
2.3. Differential hybridization screening and clone analysis 
The detection of differentially expressed human retinal cDNAs in a 
;Igtl 1 library (Clontech) was based on the method of Leonard et al. [8] 
and has been previously described [6]. Cloned cDNA inserts were am- 
plified by PCR using vector-specific primers, and subcloned into the 
vector pCRI1 (Invitrogen) for sequencing using automated sequencers 
(A.L.F., Pharmacia Biotech, Sweden; 373A, Applied Biosystems, 
USA). Sequences were analysed using the Genetics Computer Group 
(Wisconsin) Version 7 (1991) program, made available through the 
Human Genome Mapping Project Resource Centre, Harrow, UK. 
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2.4. Hybrid cell line DNAs and Southern blotting 
Rodent-human hybrid cell line DNAs and control human and rodent 
genomic DNAs (BIOS Laboratories, Inc., USA; -4,ug quantities) were 
digested with EcoRI and Southern blotted, prior to hybridization with 
the 32P-radiolabelled cDNA insert and autoradiography using standard 
protocols [9]. The human chromosome content of the hybrids was as 
follows: Hybrid #683: chromosomes 1, 5 (with multiple deletions), 12, 
14, 19, 21, 22; #803: 4, 5, 8, 22, X; #1099: 1, 5 (with deletions), 13, 19, 
21, 22; #811: 8, 17, 18; #1079: 3, 5; #423: 3 only. 
3. Results 
Differential screening of the human retinal cDNA library 
using single-stranded cDNA probes from control and simplex 
RP-affected retinal RNAs gave rise to a panel of 35 clones, the 
analysis of some of which, including clusterin, has been re- 
ported [6]. In this study, we isolated by vector-primer PCR a 
further cDNA insert (K222) which showed differential signal 
intensity between simplex RP and control retina RNAs when 
used to probe an RNA dot blot (Fig. 1A) or Northern blot (Fig. 
2A). When expressed as  ratio of signal intensity to the control 
actin probe (Fig. lB), a 5- to lo-fold over-expression of K222 
was detected in retinal RNAs from donors with simplex RP 
compared to those from unaffected donors or from the donor 
with carrier status for X-linked RP (Fig. 1C). The mini-North- 
ern blot resolved two major hybridizing transcripts, of approx- 
imately 4.5 and 2.5 kb (Fig. 2A). High levels of expression were 
detected in the RP retinal RNA; faint hybridizing bands were 
visible in the other tissue RNAs on the original autoradiograph. 
The high expression in RP was not due to variable loading or 
integrity of the RNA as the corresponding plot normalized to 
actin expression shows (Fig. 2B,C). 
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Fig. 1. RNA dot blot analysis of K222 expression i human tissues. One 
microgram samples of RNA from: 1, control retina, NR 1; 2, dystrophic 
retina, RPI; 3, control retina, NR2; 4, dystrophic retina, RP2; 5, retina 
from affected carrier, RP3; 6, retina from unaffected donor, RP4. 
Probed with (A) K222 cDNA; (B) actin cDNA; the weak actin signal 
is a consequence of repeated reprobing of the blot. (C) Expression of 
K222 standardized to that of actin for each sample by laser densitom- 
etric analysis. 
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Fig. 2. Northern blot analysis of K222 expression. Samples, -3 pg each, 
of RNA from: 1, dystrophic retina RP2; 2, control retina NR3; 3, 
control brain (cortex) NBr; 4, control liver NLv. Probed with (A) K222 
cDNA; (B) actin cDNA. (C) Expression of K222 (4.5 kb transcript) 
standardized to that of actin using laser densitometric analysis. 
Comparison of the partial sequence of clone K222 (Acces- 
sion No. X77690) against the EMBL and GenBank Databases 
(releases 39.0 and 83.0, respectively) showed -79% similarity 
with a cDNA corresponding to the mouse homologue of a 
recently described gene termed tissue inhibitor of metallopro- 
teinases-3 (TIMP3; Accession No. 230970 [lo]). Three se- 
quences of the human TIMP3 cDNA have been reported [l l- 
131, as well as the additional characterization of TIMP3 cDNAs 
from mouse [14] and chicken [15], but K222 did not show 
significant similarity to any of these. This was due to the region 
of similarity with the first murine clone extending 3’ beyond the 
end of these published sequences (Fig. 3). In order to confirm 
that K222 corresponded to a 3’ extension of the human TIMP3 
sequence, we used primers derived from our own and from the 
published human sequence (relative positions shown in Fig. 3) 
in a reverse transcription PCR applied to human retinal RNA. 
A single product of the predicted size, - 1.4 kb, was amplified and 
subcloned into pCRI1 (data not shown). Partial sequence anal- 
ysis of this clone, K222TA2 (Accession No. X80791), indicated 
that the product corresponded to a 3’ extension of the reported 
human TIMP3 cDNAs (Fig. 4), divergence beginning at nucle- 
otide 1229 based on the sequence of Silbiger et al. [12]. The 
novel human sequence reported here shows -60% identity with 
the murine TIMP3 cDNA of Sun et al. [lo]. We also used K222 
as a probe on Southern blots of rodent-human hybrid cell lines 
to test whether the cDNA mapped to chromosome 22, as estab- 
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Fig. 3. Schematic representation of sequence alignment between clones of mouse TIMP3 (MTIMP3, [lo]), human TIMPS (HTIMP3, [12]) and clone 
K222. Numbers indicate base positions (0 at the 5’ end). Primers Pril and Pri2 used for reverse transcription PCR are indicated by arrows (not to 
scale), and the sequenced region of the resulting PCR product (see Fig. 4) is also shown. 
lished for human TIMP3 [ 111. A single hybridizing band of 2.4 
kb was detected in human genomic DNA, with no detectable 
bands in rodent DNA (Fig. 5). The pattern of positive and 
negative hybrids confirmed mapping of K222 to human chro- 
mosome 22. 
4. Discussion 
In extending our analysis of altered gene expression associ- 
ated with the dystrophic state in human retinas affected by 
retinitis pigmentosa, we identified over-expression of a clone, 
K222, occurring in retinal RNA from donors with simplex RP 
in contrast to controls and to affected carrier and unaffected 
donors. Partial sequence data from clone K222 showed 79% 
similarity with a cloned cDNA of the mouse homologue of 
tissue inhibitor of metalloproteinases-3 (TIMP3) [lo], although 
the sequence did not overlap that of published human TIMP3 
cDNAs. Our data indicate that K222 most likely corresponds 
to part of the 3’ extension of an alternative transcriptional 
species of the human gene, since (i) reverse transcription PCR 
of human retinal RNA using primers from the K222 and 
human TIMP3 sequences amplifies a single product of the 
predicted size, incorporating a sequence identical up to the 
poly(A) terminus of the human cDNA; and (ii) mapping of 
K222 to chromosome 22 accords with the results of Apte et al. 
for the localization of the human TIMP3 gene [l 11. The unusu- 
ally high similarity of the putative untranslated 3’ sequence 
between the human and mouse clones (-60-80% over extended 
regions of 200 nucleotides or more) also parallels similarities 
observed by Leco et al. [ 141 between mouse and chicken TIMP3 
cDNAs in comparing the 3’-untranslated sequences of (presum- 
ably) the shorter transcriptional forms. As suggested by these 
investigators, the similarities may reflect regulatory functions 
of the 3’ region, such as stabilization of TIMP3 transcripts or 
modulation of their translation. 
The tissue inhibitors of metalloproteinases (TIMPs) are a 
family of polypeptides which bind and inhibit matrix metal- 
loproteinases (MMPs) such as collagenases and gelatinases (for 
review see e.g. [16]). The controlled expression of the proteases 
and their inhibitors is critical for the regulation of the structure 
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Fig. 4. Partial sequence of the cloned PCR product (K222TA2) amplified using primers 1 and 2 indicated in Fig. 3. The sequence is deposited in 
the GenBank and EMBL Databases with the Accession Number X80791. The sequence shows 100% identity with the 3’ end of the human TIMP3 
cDNA [12] to base 1229, numbered asin the original publication. 
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Fig. 5. Southern blot analysis of EcoRI-digested rodent-human hybrid 
cell line and control DNAs (~4 pg samples) probed with K222 cDNA. 
1, hybrid #683; 2, #803; 3, #1099; 4, #811; 5, human genomic; 
6, hamster genomic; 7, mouse genomic; 8, hybrid #1079; 9, #423 DNA. 
and composition of the extracellular matrix (ECM), a dynamic 
compartment involved in a range of normal and pathological 
processes. Imbalances between the metalloproteinases and 
their inhibitors and activators, leading to increased ECM deg- 
radation, have been implicated in, for example, osteodegenera- 
tive arthritis and tumour invasion. The expression of TIMPs 
and of the proteases is regulated by numerous factors, including 
transforming growth factor-beta (TGF-B), which has a stimula- 
tory effect on TIMP expression but inhibits metalloproteinase 
transcription (reviewed in [ 161). 
Human TIMP3 is the homologue of a gene first characterized 
in chicken (ChIMP-3) as the third member of the TIMP family, 
encoding a 21 kDa ECM protein from embryonic fibroblasts, 
and showing increased levels during oncogenic transformation 
[ 15,171. The expression of human TIMP3 mRNA has been 
reported in a range of normal human tissues and tumour cell 
lines [11-131, notably at high levels in placenta. Three tran- 
scripts are detected by Northern blot, the largest of 4.4-5.5 kb, 
and the two smaller transcripts at 2.2-2.4 and 2.5-2.8 kb; it is 
likely in this study that the mini-Northern blot failed to resolve 
the smaller transcripts. This is the first observation of TIMP3 
expression in ocular tissues, although matrix metallopro- 
teinases and TIMPl have been identified in cultured human 
retinal pigment epithelium (RPE) [18], and, in the developing 
neural retina, metalloproteinases have been postulated to play 
a role in facilitating neurite extension [ 191. Recent preliminary 
studies have also identified MMPs and TIMP2 in the interpho- 
toreceptor matrix and vitreous humour [20]. Three observa- 
tions may be of relevance in interpreting the significance of 
increased TIMP3 expression in retinas affected by simplex RP. 
Firstly, Alexander et al. [18] reported that two cultured RPE 
cell lines from patients with RP showed over-expression of 
metalloproteinase activities, although those from other RP 
cases showed normal levels (the genetic types of RP were not 
stated). Secondly, up-regulation of genes associated with ECM 
turnover has been closely linked to the phenomenon of apopto- 
sis (e.g. [21]), the mechanism responsible for the final stages of 
photoreceptor cell death in several rodent models of RP [3-51. 
Thirdly, the recent report that disruption of cell-matrix interac- 
tions can induce apoptosis in epithelial cells (‘anoikis’, [22]) 
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indicates the critical significance of maintenance of anchorage 
to the integrity of the cell. Our own observations, that a gene, 
TIMP3, implicated in ECM remodelling, is over-expressed in
retinas affected by simplex retinitis pigmentosa, suggest at the 
very least that substantial restructuring of the retinal ECM 
(including presumably the interphotoreceptor matrix) is occur- 
ring in this type of disease. Potentially, the primary gene defects 
may lead to disruption of photoreceptor-matrix interactions, 
possibly via dysregulatory effects on RPE metalloproteinases. 
The concomitant loss of critical maintenance signals from the 
matrix via membrane receptors could contribute to the activa- 
tion of apoptotic processes in the photoreceptors themselves. 
Further insight into the relationship between TIMP3 over-ex- 
pression and photoreceptor degeneration may be gained by 
analysis of other agents modulating the integrity of the retinal 
extracellular matrix. 
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